ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing Study

NARecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

February 12, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions
Breast Cancer
Interventions
DRUG

Indocyanine green

"Indocyanine green dye (Diagnostic Green) will be diluted with sterile water and a specific dose-arm (0.125 mg/kg, 0.25 mg/kg, 05 mg/kg, 1 mg/kg, and 2 mg/kg) will be administrated by slow intravenous injection by peripheral venous catheter:~* at induction anaesthesia of the surgical procedure (0.125 mg/kg or 0.25mg/kg), or~* in the hospital room 24 hours before the breast surgery (05 mg/kg, or 1 mg/kg, or 2 mg/kg)."

Trial Locations (1)

1070

RECRUITING

Jules Bordet Institute, Brussels

Sponsors
All Listed Sponsors
lead

Jules Bordet Institute

OTHER

NCT06227338 - ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing Study | Biotech Hunter | Biotech Hunter